The epigenetics of epithelial-mesenchymal plasticity in cancer
暂无分享,去创建一个
[1] D. Solter,et al. Stabilization of β-catenin in the mouse zygote leads to premature epithelial-mesenchymal transition in the epiblast , 2004, Development.
[2] Sun-Mi Park,et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.
[3] S. Morrison,et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation , 2003, Nature.
[4] D. Dufort,et al. β‐catenin signaling marks the prospective site of primitive streak formation in the mouse embryo , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.
[5] A. Mills. Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins , 2010, Nature Reviews Cancer.
[6] Chi Wang,et al. Interaction with Suv39H1 is Critical for Snail-mediated E-cadherin Repression in Breast Cancer , 2012, Oncogene.
[7] A. Chinnaiyan,et al. The emergence of lncRNAs in cancer biology. , 2011, Cancer discovery.
[8] Yibin Kang,et al. Multilayer control of the EMT master regulators , 2014, Oncogene.
[9] Johan Eide,et al. Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] Yukinori Endo,et al. Regulation of Slug transcription in embryonic ectoderm by β‐catenin‐Lef/Tcf and BMP‐Smad signaling , 2005, Development, growth & differentiation.
[11] Michael F Clarke,et al. The biology of cancer stem cells. , 2007, Annual review of cell and developmental biology.
[12] Elgene Lim,et al. Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells. , 2013, Cancer cell.
[13] T. Brabletz. To differentiate or not — routes towards metastasis , 2012, Nature Reviews Cancer.
[14] L. Carey,et al. Triple-negative breast cancer: disease entity or title of convenience? , 2010, Nature Reviews Clinical Oncology.
[15] E. Hay,et al. DIRECT EVIDENCE FOR A ROLE OF β‐CATENIN/LEF‐1 SIGNALING PATHWAY IN INDUCTION OF EMT , 2002, Cell biology international.
[16] M. Katoh,et al. Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review). , 2008, International journal of molecular medicine.
[17] Peter A. Jones,et al. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment. , 2002, Blood.
[18] C. Heldin,et al. Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression , 2007, Cancer science.
[19] A. Postigo,et al. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness , 2011, Proceedings of the National Academy of Sciences.
[20] J. Lachuer,et al. EMT Inducers Catalyze Malignant Transformation of Mammary Epithelial Cells and Drive Tumorigenesis towards Claudin-Low Tumors in Transgenic Mice , 2012, PLoS genetics.
[21] Jeffrey M. Rosen,et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.
[22] S. Frisch. The epithelial cell default‐phenotype hypothesis and its implications for cancer , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.
[23] Alberto Martin,et al. Tumorigenesis: Twist1 links EMT to self-renewal , 2010, Nature Cell Biology.
[24] Jianguo Song,et al. Histone deacetylase 1 is required for transforming growth factor-beta1-induced epithelial-mesenchymal transition. , 2010, The international journal of biochemistry & cell biology.
[25] A. Schulze,et al. Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. , 2000, Genes & development.
[26] Howard Y. Chang,et al. Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.
[27] S. Weiss,et al. A Wnt–Axin2–GSK3β cascade regulates Snail1 activity in breast cancer cells , 2006, Nature Cell Biology.
[28] R. Weinberg,et al. Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. , 2012, Cancer discovery.
[29] J. Dering,et al. Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro , 2007, Breast Cancer Research and Treatment.
[30] Mary Anne Wheeler,et al. Stem , 1985 .
[31] J. Settleman,et al. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer , 2010, Oncogene.
[32] H. Ford,et al. Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.
[33] V. Orlando. Polycomb, Epigenomes, and Control of Cell Identity , 2003, Cell.
[34] S. Dhanasekaran,et al. Repression of E-cadherin by the polycomb group protein EZH2 in cancer , 2008, Oncogene.
[35] Qiang Yu,et al. BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A , 2009, Breast Cancer Research.
[36] David A. Orlando,et al. Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers , 2013, Cell.
[37] J. Kjems,et al. Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer , 2010 .
[38] Sean J Morrison,et al. Bmi1, stem cells, and senescence regulation. , 2004, The Journal of clinical investigation.
[39] H. Cedar,et al. Linking DNA methylation and histone modification: patterns and paradigms , 2009, Nature Reviews Genetics.
[40] Massimo Cristofanilli,et al. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013 .
[41] I. Pogribny,et al. E‐cadherin transcriptional down‐regulation by epigenetic and microRNA‐200 family alterations is related to mesenchymal and drug‐resistant phenotypes in human breast cancer cells , 2010, International journal of cancer.
[42] M. Bushell,et al. microRNAs in cancer management. , 2012, The Lancet. Oncology.
[43] Yarong Wang,et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. , 2007, Cancer research.
[44] R. Schwendener,et al. Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors , 2012, BMC Cancer.
[45] Maximilian Reichert,et al. EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.
[46] C. D. Salcido,et al. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics , 2008, Breast Cancer Research.
[47] M. van Lohuizen,et al. Stem cell regulation by polycomb repressors: postponing commitment. , 2008, Current opinion in cell biology.
[48] Dario Strbenac,et al. Regional activation of the cancer genome by long-range epigenetic remodeling. , 2013, Cancer cell.
[49] Paul A. Wiggins,et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state , 2011, Proceedings of the National Academy of Sciences.
[50] I. Haviv,et al. Epigenetic Regulation of Cell Type–Specific Expression Patterns in the Human Mammary Epithelium , 2011, PLoS genetics.
[51] Mark D. Robinson,et al. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity , 2010, Nature Cell Biology.
[52] Debashis Ghosh,et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[53] H. Allgayer,et al. Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non–Small Cell Lung Cancer , 2010, Molecular Cancer Research.
[54] Qun Zhou,et al. miR-200a Regulates SIRT1 Expression and Epithelial to Mesenchymal Transition (EMT)-like Transformation in Mammary Epithelial Cells* , 2011, The Journal of Biological Chemistry.
[55] J. Qin,et al. The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis , 2011, Cell Research.
[56] H. Beug,et al. TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis , 1998, Current Biology.
[57] William B. Smith,et al. Selective inhibition of BET bromodomains , 2010, Nature.
[58] Alan Wells,et al. Partial Mesenchymal to Epithelial Reverting Transition in Breast and Prostate Cancer Metastases , 2012, Cancer Microenvironment.
[59] C. Croce,et al. p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2 , 2011, The Journal of experimental medicine.
[60] J. Issa,et al. Comment on "Chromosomal Instability and Tumors Promoted by DNA Hypomethylation" and "Induction of Tumors in Mice by Genomic Hypomethylation" , 2003, Science.
[61] P. Pelicci,et al. Complete remission through blast cell differentiation in PLZF/RARalpha-positive acute promyelocytic leukemia: in vitro and in vivo studies. , 2002, Blood.
[62] Howard Y. Chang,et al. Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.
[63] Stuart Thomson,et al. A systems view of epithelial–mesenchymal transition signaling states , 2010, Clinical & Experimental Metastasis.
[64] R. Weinberg,et al. Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.
[65] Kenneth M. Yamada,et al. The Zinc-finger Protein Slug Causes Desmosome Dissociation, an Initial and Necessary Step for Growth Factor–induced Epithelial–mesenchymal Transition , 1997 .
[66] M. Bernstein,et al. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells. , 2003, Leukemia research.
[67] R. Schüle,et al. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. , 2010, Carcinogenesis.
[68] M. Capecchi,et al. Bmi1 lineage tracing identifies a self-renewing pancreatic acinar cell subpopulation capable of maintaining pancreatic organ homeostasis , 2009, Proceedings of the National Academy of Sciences.
[69] Antoine H. F. M. Peters,et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription , 2005, Nature.
[70] Jun Yao,et al. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. , 2012, The Journal of clinical investigation.
[71] S. Baylin,et al. Epigenetic abnormalities in cancer find a "home on the range". , 2013, Cancer cell.
[72] B. Zhou,et al. The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine‐specific demethylase 1 , 2010, The EMBO journal.
[73] Simone Brabletz,et al. The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer? , 2010, EMBO reports.
[74] Tae Jin Lee,et al. p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2 , 2011, The Journal of experimental medicine.
[75] Louis Vermeulen,et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.
[76] J. Carroll,et al. Pioneer transcription factors: establishing competence for gene expression. , 2011, Genes & development.
[77] M. Nieto,et al. The ins and outs of the epithelial to mesenchymal transition in health and disease. , 2011, Annual review of cell and developmental biology.
[78] Jing Yang,et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. , 2012, Cancer cell.
[79] M. Nieto,et al. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. , 2009, The Journal of clinical investigation.
[80] Robert A. Weinberg,et al. Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity , 2013, Cell.
[81] S. Leng,et al. EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. , 2011, Cancer research.
[82] K. Helin,et al. Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription Factor , 2008, Molecular and Cellular Biology.
[83] J. Herman,et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.
[84] Yi Qu,et al. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells , 2010, BMC Genomics.
[85] C. Lengauer. Cancer. An unstable liaison. , 2003, Science.
[86] M. Korpal,et al. The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2* , 2008, Journal of Biological Chemistry.
[87] S. Morrison,et al. Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors. , 2005, Cold Spring Harbor symposia on quantitative biology.
[88] Christoph Lengauer,et al. An Unstable Liaison , 2003, Science.
[89] Anke Sparmann,et al. Polycomb silencers control cell fate, development and cancer , 2006, Nature Reviews Cancer.
[90] Yang Shi,et al. Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1 , 2004, Cell.
[91] R. Young,et al. BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc , 2011, Cell.
[92] Kristian Helin,et al. Polycomb group proteins: navigators of lineage pathways led astray in cancer , 2009, Nature Reviews Cancer.
[93] D. Patel,et al. A Poised Chromatin Platform for TGF-β Access to Master Regulators , 2011, Cell.
[94] A Chaix,et al. KIT-D816V oncogenic activity is controlled by the juxtamembrane docking site Y568-Y570 , 2014, Oncogene.
[95] Sophia Hsin-Jung Li,et al. Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast , 2011, Cell.
[96] E. Ballestar,et al. Snail Mediates E-Cadherin Repression by the Recruitment of the Sin3A/Histone Deacetylase 1 (HDAC1)/HDAC2 Complex , 2004, Molecular and Cellular Biology.
[97] G. Goodall,et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.
[98] A. Dimmler,et al. The ZEB 1 / miR-200 feedback loop controls Notch signaling in cancer cells , 2010 .
[99] Howard Y. Chang,et al. Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.
[100] M. F. Shannon,et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. , 2008, Cancer research.
[101] H. Clevers,et al. Wnt signalling in stem cells and cancer , 2005, Nature.
[102] F. Slack,et al. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy , 2011, Nature Reviews Cancer.
[103] B. Teh,et al. Methylation Subtypes and Large-Scale Epigenetic Alterations in Gastric Cancer , 2012, Science Translational Medicine.
[104] W. Woodward,et al. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling. , 2011, Cancer cell.
[105] M. Caraglia,et al. HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT , 2011, Journal of cellular physiology.
[106] Martin Dugas,et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia , 2012, Nature Medicine.
[107] Bob Y. Liu,et al. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[108] K. Struhl,et al. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. , 2010, Molecular cell.
[109] Ajamete Kaykas,et al. WNT and β-catenin signalling: diseases and therapies , 2004, Nature Reviews Genetics.
[110] Gema Moreno-Bueno,et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. , 2008, Cancer research.
[111] E. Hay,et al. Cell contact during early morphogenesis in the chick embryo. , 1967, Developmental biology.
[112] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[113] B. Bao,et al. Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells , 2012, PLoS ONE.
[114] C. Cordon-Cardo,et al. Autocrine PDGFR signaling promotes mammary cancer metastasis. , 2006, The Journal of clinical investigation.
[115] Kristian Helin,et al. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. , 2006, Genes & development.
[116] Arthur,et al. Inhibition of the LSD 1 ( KDM 1 A ) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia , 2013 .
[117] J. Foidart,et al. Transactivation of Vimentin by β-Catenin in Human Breast Cancer Cells , 2003 .
[118] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[119] G. Berx,et al. Regulatory networks defining EMT during cancer initiation and progression , 2013, Nature Reviews Cancer.
[120] C. Catapano,et al. ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features. , 2012, Cancer research.
[121] R. Hipskind,et al. Erk5 controls Slug expression and keratinocyte activation during wound healing. , 2008, Molecular biology of the cell.
[122] Jenny G. Parvani,et al. The Pathophysiology of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β in Normal and Malignant Mammary Epithelial Cells , 2010, Journal of Mammary Gland Biology and Neoplasia.
[123] M. Nieto,et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. , 2012, Cancer cell.
[124] N. Cho,et al. Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial–mesenchymal transition-like state in breast cancer cells in vitro , 2010, Journal of Cell Science.
[125] B. Bao,et al. Activated K‐Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype , 2013, Journal of cellular physiology.
[126] R. Jaenisch,et al. Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.
[127] Jiri Zavadil,et al. TGF-β and epithelial-to-mesenchymal transitions , 2005, Oncogene.
[128] R. Huang,et al. Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.
[129] R. Eferl,et al. Hepatic tumor–stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge , 2009, Oncogene.
[130] Zhiwei Wang,et al. Platelet‐Derived Growth Factor‐D Overexpression Contributes to Epithelial‐Mesenchymal Transition of PC3 Prostate Cancer Cells , 2008, Stem cells.
[131] E. Lander,et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. , 2008, Cancer research.
[132] L. Tran,et al. Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. , 2012, Cancer research.
[133] Susan G Hilsenbeck,et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. , 2008, Journal of the National Cancer Institute.
[134] Kristian Helin,et al. The emerging functions of histone demethylases. , 2008, Current opinion in genetics & development.
[135] M. Choti,et al. Histone deacetylase inhibition suppresses the transforming growth factor β1–induced epithelial‐to‐mesenchymal transition in hepatocytes , 2010, Hepatology.
[136] Guy S. Salvesen,et al. SnapShot: Caspases , 2011, Cell.
[137] M. Taketo. Shutting down Wnt signal–activated cancer , 2004, Nature Genetics.
[138] Irving L. Weissman,et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.
[139] Simone Brabletz,et al. The ZEB1/miR‐200 feedback loop controls Notch signalling in cancer cells , 2011, The EMBO journal.
[140] Crispin J. Miller,et al. The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. , 2012, Cancer cell.
[141] Hao Wang,et al. Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression. , 2013, Biochimica et biophysica acta.
[142] Xin Hu,et al. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition , 2010, Oncogene.
[143] D. Saur,et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. , 2009, Gastroenterology.
[144] M. Waltham,et al. Epithelial mesenchymal transition traits in human breast cancer cell lines , 2008, Clinical & Experimental Metastasis.
[145] Chi-Hung Huang,et al. Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition , 2010, Nature Cell Biology.
[146] R. B. Redmon,et al. Identity , 2021, Notre Dame J. Formal Log..
[147] Mary J. C. Hendrix,et al. ErbB/EGF Signaling and EMT in Mammary Development and Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.
[148] A. Bird. DNA methylation patterns and epigenetic memory. , 2002, Genes & development.
[149] K. Pantel,et al. Plasticity of disseminating cancer cells in patients with epithelial malignancies , 2012, Cancer and Metastasis Reviews.
[150] A. Puisieux,et al. Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.
[151] H. Clevers,et al. Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties , 2013, Cell.
[152] Luyang Sun,et al. LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer , 2009, Cell.
[153] K. Mostov,et al. Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis. , 2007, Molecular biology of the cell.
[154] Wenjun Guo,et al. Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State , 2012, Cell.
[155] S. Ramaswamy,et al. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.
[156] M. Lohuizen,et al. Stem Cells and Cancer The Polycomb Connection , 2004, Cell.
[157] D. Barritault,et al. Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[158] D. Riesner,et al. Induction of Tumors in Mice by Genomic Hypomethylation , 2003 .
[159] M. Esteller,et al. Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis , 2011, Oncogene.
[160] H. Trompeter,et al. Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells , 2010, BMC Research Notes.
[161] Martha R. Stampfer,et al. Role for DNA Methylation in the Regulation of miR-200c and miR-141 Expression in Normal and Cancer Cells , 2010, PloS one.
[162] Héctor Peinado,et al. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.
[163] Wenlin Huang,et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. , 2009, The Journal of clinical investigation.
[164] A. Iwama,et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. , 2004, Immunity.
[165] C. Corless,et al. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. , 2005, The Journal of clinical investigation.
[166] David A. Orlando,et al. Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.
[167] G. Moreno-Bueno,et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas , 2002, Oncogene.
[168] R. Mayor,et al. Neural crest delamination and migration: from epithelium-to-mesenchyme transition to collective cell migration. , 2012, Developmental biology.
[169] Tim J. Wigle,et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. , 2012, Nature chemical biology.
[170] Yonghong Xiao,et al. Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. , 2011, Cancer cell.
[171] R. Weinberg,et al. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.
[172] Julia Schüler,et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.
[173] James A. Cuff,et al. A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.